Mimedx Group Inc (MDXG)

$5.99 -0.05 (-0.83%)
Market Cap 892.12M
Revenue (ttm) 348.88M
Net Income (ttm) 42.42M
EPS (ttm) N/A
PE Ratio 21.86
Forward PE 23.54
Profit Margin 12.16%
Debt to Equity Ratio 0.01
Volume 518,400
Avg Vol 687,688
Day's Range N/A - N/A
Shares Out 147.70M
Stochastic %K 24%
Beta 1.82
Analysts Strong Sell
Price Target $12.00

Company Profile

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techni...

Industry: Biotechnology
Sector: Healthcare
Phone: 770 651 9100
Address:
1775 West Oak Commons Court, NE, Marietta, United States
Big_Baggies
Big_Baggies Jun. 17 at 1:41 PM
$MDXG Have the CEO and CFO been arrested yet?!
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 17 at 12:33 PM
$MDXG Time to sell this to highest bidder and move on. Leadership has proven, over years, incapable of getting it done.
0 · Reply
biomaster22
biomaster22 Jun. 17 at 11:58 AM
$MDXG I have also posted before how does Katherine Behrens even have a board position she has contributed nothing and failure just follows her. Coincidence I think not - this managment and board shoudl all be fired !
1 · Reply
FinancialScience
FinancialScience Jun. 17 at 3:33 AM
$MDXG https://biotechhealthx.com/biotech-news/organogenesis-orgo-the-3-stock-disrupting-wound-healing-regenerative-medicine/
0 · Reply
FinancialScience
FinancialScience Jun. 17 at 12:21 AM
$MDXG any mdxg shareholder who does not swap their mdxg shares for orgo shares is a dummy
0 · Reply
loungepet
loungepet Jun. 16 at 8:07 PM
$MDXG my language has gotten progressively worse since buying this in 2016.
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 16 at 7:43 PM
$MDXG
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 16 at 7:10 PM
$MDXG $5.47 is next resistance.
1 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 16 at 5:44 PM
$MDXG Why is Behrens on our board let alone COB? Capper declared from day 1 that mdxg is a medtech company yet our board are biotech. Capper and Marty driving this into the ditch. Great call scrapping KOA guys!
0 · Reply
GlobalInsights
GlobalInsights Jun. 16 at 4:25 PM
$MDXG Wow are chairwomen has really screwed up SRPT down another 45% today. She is a disaster and should be removed from MDXG! https://www.statnews.com/2025/06/15/duchenne-sarepta-gene-therapy-elevidys-patient-death/
0 · Reply
Latest News on MDXG
MIMEDX to Participate in Upcoming Investor Conferences

May 27, 2025, 8:00 AM EDT - 21 days ago

MIMEDX to Participate in Upcoming Investor Conferences

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

May 6, 2025, 8:00 AM EDT - 6 weeks ago

MIMEDX to Present at the BofA Securities 2025 Healthcare Conference

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

May 5, 2025, 8:30 AM EDT - 6 weeks ago

MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 9:52 PM EDT - 6 weeks ago

MiMedx Group, Inc. (MDXG) Q1 2025 Earnings Call Transcript

MIMEDX Announces First Quarter 2025 Operating and Financial Results

Apr 30, 2025, 4:01 PM EDT - 6 weeks ago

MIMEDX Announces First Quarter 2025 Operating and Financial Results

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

Apr 10, 2025, 4:01 PM EDT - 2 months ago

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

Feb 27, 2025, 8:00 AM EST - 3 months ago

MIMEDX to Present at TD Cowen 45th Annual Health Care Conference

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 10:50 PM EST - 3 months ago

MiMedx Group, Inc. (MDXG) Q4 2024 Earnings Call Transcript

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

Feb 26, 2025, 4:01 PM EST - 3 months ago

MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial Results

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

Nov 14, 2024, 9:15 AM EST - 7 months ago

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 9:38 PM EDT - 8 months ago

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

Oct 30, 2024, 4:01 PM EDT - 8 months ago

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

Oct 14, 2024, 8:00 AM EDT - 8 months ago

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

Oct 8, 2024, 4:01 PM EDT - 8 months ago

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

Oct 1, 2024, 4:01 PM EDT - 9 months ago

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

Sep 11, 2024, 1:03 PM EDT - 9 months ago

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

Sep 4, 2024, 4:23 PM EDT - 10 months ago

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

Aug 26, 2024, 9:30 AM EDT - 10 months ago

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 9:10 PM EDT - 11 months ago

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

Jul 31, 2024, 4:02 PM EDT - 11 months ago

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

Jul 31, 2024, 4:01 PM EDT - 11 months ago

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

Jul 22, 2024, 8:10 AM EDT - 11 months ago

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

Jun 26, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 9:33 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

MIMEDX Announces First Quarter 2024 Operating and Financial Results

Apr 30, 2024, 4:01 PM EDT - 1 year ago

MIMEDX Announces First Quarter 2024 Operating and Financial Results

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

Apr 16, 2024, 8:00 AM EDT - 1 year ago

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

Mar 20, 2024, 7:00 AM EDT - 1 year ago

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 8:46 PM EST - 1 year ago

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

Feb 28, 2024, 4:01 PM EST - 1 year ago

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

Feb 20, 2024, 8:00 AM EST - 1 year ago

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

Feb 12, 2024, 8:00 AM EST - 1 year ago

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing

Jan 22, 2024, 8:00 AM EST - 1 year ago

MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

Jan 12, 2024, 4:00 PM EST - 1 year ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

Jan 11, 2024, 12:54 PM EST - 1 year ago

The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

MiMedx reports US FDA warning letter for Axiofill, shares drop

Dec 29, 2023, 7:01 PM EST - 1 year ago

MiMedx reports US FDA warning letter for Axiofill, shares drop

MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

Dec 29, 2023, 5:00 PM EST - 1 year ago

MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

Dec 28, 2023, 8:00 AM EST - 1 year ago

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

MIMEDX to Highlight Published Data at SAWC Fall

Nov 2, 2023, 8:00 AM EDT - 1 year ago

MIMEDX to Highlight Published Data at SAWC Fall

MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call Transcript

Oct 30, 2023, 9:17 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call Transcript

MIMEDX Announces Third Quarter 2023 Operating and Financial Results

Oct 30, 2023, 4:01 PM EDT - 1 year ago

MIMEDX Announces Third Quarter 2023 Operating and Financial Results

MiMedx Group, Inc. (MDXG) Q2 2023 Earnings Call Transcript

Aug 1, 2023, 6:48 PM EDT - 2 years ago

MiMedx Group, Inc. (MDXG) Q2 2023 Earnings Call Transcript

MIMEDX Announces Second Quarter 2023 Operating and Financial Results

Aug 1, 2023, 4:01 PM EDT - 2 years ago

MIMEDX Announces Second Quarter 2023 Operating and Financial Results

MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1

Jul 18, 2023, 8:00 AM EDT - 2 years ago

MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1

MIMEDX Appoints Doug Rice as Chief Financial Officer

Jul 5, 2023, 8:00 AM EDT - 2 years ago

MIMEDX Appoints Doug Rice as Chief Financial Officer

MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability

Jun 20, 2023, 4:01 PM EDT - 2 years ago

MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability

MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Call Transcript

May 2, 2023, 11:08 PM EDT - 2 years ago

MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Call Transcript

MIMEDX Announces First Quarter 2023 Operating and Financial Results

May 2, 2023, 4:01 PM EDT - 2 years ago

MIMEDX Announces First Quarter 2023 Operating and Financial Results

MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2

Apr 18, 2023, 8:00 AM EDT - 2 years ago

MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2

Big_Baggies
Big_Baggies Jun. 17 at 1:41 PM
$MDXG Have the CEO and CFO been arrested yet?!
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 17 at 12:33 PM
$MDXG Time to sell this to highest bidder and move on. Leadership has proven, over years, incapable of getting it done.
0 · Reply
biomaster22
biomaster22 Jun. 17 at 11:58 AM
$MDXG I have also posted before how does Katherine Behrens even have a board position she has contributed nothing and failure just follows her. Coincidence I think not - this managment and board shoudl all be fired !
1 · Reply
FinancialScience
FinancialScience Jun. 17 at 3:33 AM
$MDXG https://biotechhealthx.com/biotech-news/organogenesis-orgo-the-3-stock-disrupting-wound-healing-regenerative-medicine/
0 · Reply
FinancialScience
FinancialScience Jun. 17 at 12:21 AM
$MDXG any mdxg shareholder who does not swap their mdxg shares for orgo shares is a dummy
0 · Reply
loungepet
loungepet Jun. 16 at 8:07 PM
$MDXG my language has gotten progressively worse since buying this in 2016.
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 16 at 7:43 PM
$MDXG
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 16 at 7:10 PM
$MDXG $5.47 is next resistance.
1 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 16 at 5:44 PM
$MDXG Why is Behrens on our board let alone COB? Capper declared from day 1 that mdxg is a medtech company yet our board are biotech. Capper and Marty driving this into the ditch. Great call scrapping KOA guys!
0 · Reply
GlobalInsights
GlobalInsights Jun. 16 at 4:25 PM
$MDXG Wow are chairwomen has really screwed up SRPT down another 45% today. She is a disaster and should be removed from MDXG! https://www.statnews.com/2025/06/15/duchenne-sarepta-gene-therapy-elevidys-patient-death/
0 · Reply
WayneProv3
WayneProv3 Jun. 16 at 4:22 PM
$MDXG I sold 5,000 MDXG and decided to buy some ORGO due to them moving (possibly) to phase 3 of KOA. Anyone else own both companies? Thoughts?
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 16 at 1:03 PM
$MDXG Behrens doing a heck of a job at Sarepta (down 37% this morning). Why is she head of mdxg board? Why is our board dominated by biotech folks when we are a shitty medtech company that isnt growing?
1 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 16 at 12:35 AM
$MDXG This dumpster fire needs leadership. Will we see $4’s again this year?
0 · Reply
SnapCrackleStop
SnapCrackleStop Jun. 13 at 2:01 PM
$MDXG Mr Market not happy with MDXG. Rumored deal coming…. Maybe they are investing in air??? $
2 · Reply
Telluwhat
Telluwhat Jun. 12 at 9:03 PM
$MDXG ⚰️😩
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 12 at 8:28 PM
$MDXG We are almost at same price as 5 years ago…….Capper is awful.
0 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jun. 12 at 8:20 PM
$MDXG Technicals couldnt be much worse. $6 is about to be tested, incredible.
0 · Reply
MrStealYourShares
MrStealYourShares Jun. 12 at 8:01 PM
$MDXG order still at $6..
1 · Reply
CharlyBue
CharlyBue Jun. 12 at 7:59 PM
$MDXG Every day SP down, cpy should probably be bought cheap Who is the white knight?
0 · Reply
SnapCrackleStop
SnapCrackleStop Jun. 12 at 6:42 PM
$MDXG management.
0 · Reply
GlobalInsights
GlobalInsights Jun. 12 at 5:41 PM
$MDXG The sound of silence from mgmt continues. Executive Incompetence at its highest for those who put their hard earned money into this expecting mgmt to creat value, not destroy it!
0 · Reply
ta99bobotw
ta99bobotw Jun. 12 at 4:34 PM
$MDXG ... ☹️
0 · Reply